Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus (HIV)-1 Infection”

591 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 591 results

Early research (Phase 1)Study completedNCT02277600
What this trial is testing

Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 32
Early research (Phase 1)Study completedNCT03205917
What this trial is testing

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 29
Large-scale testing (Phase 3)Study completedNCT02600325
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

Who this might be right for
Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C
Erasmus Medical Center 80
Early research (Phase 1)Temporarily pausedNCT06905275
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT04772469
What this trial is testing

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHIV Infections+5 more
University of California, San Francisco 934
Early research (Phase 1)Study completedNCT05144386
What this trial is testing

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Who this might be right for
HIV-1-infection
Excision BioTherapeutics 6
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Testing effectiveness (Phase 2)Study completedNCT01725542
What this trial is testing

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Who this might be right for
HCV-HIV Co-Infection
ANRS, Emerging Infectious Diseases 75
Not applicableStudy completedNCT02191332
What this trial is testing

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

Who this might be right for
HIV Infections
Boehringer Ingelheim 147
Early research (Phase 1)Study completedNCT02599896
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
Prevention of HIV InfectionHIV AntibodiesMonoclonal Antibody, Human+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 49
Large-scale testing (Phase 3)Study completedNCT00990600
What this trial is testing

QoL and Adherence to One-pill Once-a-day HAART

Who this might be right for
HIV InfectionHIV Infections
A.O. Ospedale Papa Giovanni XXIII 212
Not applicableStudy completedNCT05862857
What this trial is testing

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)

Who this might be right for
HIV/AIDS
University of California, San Francisco 9,375
Early research (Phase 1)Study completedNCT00574600
What this trial is testing

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT02225665
What this trial is testing

Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART

Who this might be right for
Human Immunodeficiency Virus (HIV)
Sangamo Therapeutics 8
Large-scale testing (Phase 3)UnknownNCT00004981
What this trial is testing

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Who this might be right for
HIV Infections
Glaxo Wellcome 230
Early research (Phase 1)UnknownNCT04553016
What this trial is testing

Test Three Experimental HIV Vaccines in Healthy Adults.

Who this might be right for
HIV-1-infection
University of Oxford 88
Early research (Phase 1)Study completedNCT03307915
What this trial is testing

2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 25
Post-approval studies (Phase 4)Study completedNCT00192660
What this trial is testing

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Who this might be right for
HIV-Associated Lipodystrophy SyndromeCardiovascular Disease
Kirby Institute 80
Early research (Phase 1)Study completedNCT02082808
What this trial is testing

Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 12
Early research (Phase 1)Study completedNCT05471076
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Next Page